Developer of agonist antibody drugs intended for tumour targeting. Hengdong Shengwu is based in Zhongshan, China and was founded in 2021.
Team — not yet on record
No current team members for Hengdong Shengwu are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hengdong Shengwu with a free account
- ·Watch Hengdong Shengwu: the Monday email on marks, rounds and moves
